[Clinical experiences with Holoxan in small cell carcinoma of the bronchus (author's transl)].
Clinical experiences obtained until now in the treatment of 47 patients with small cell carcinoma of the bronchus with Holoxan are reported. Special emphasis is laid to the results of a prospective randomized study; two groups of patients, one of them undergoing Holoxan therapy, the other receiving symptomatic treatment, have been investigated in respect of relationship between tumour remission, quality of life and survival time.
D001984:Bronchial Neoplasms / Q000188:drug therapy* / Q000401:mortality; D002277:Carcinoma / Q000188:drug therapy* / Q000401:mortality; D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use*; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D011788:Quality of Life
D003520:Cyclophosphamide; D007069:Ifosfamide
Klinische Erfahrungen mit Holoxan beim kleinzelligen Bronchuskarzinom.